Print
Editor's Picks
Back « 1 2 3 4 5 6 7 8 ... » Next
Back « 1 2 3 4 5 6 7 8 ... » Next
Back « 1 2 3 4 5 6 7 8 ... » Next
- Former NIH director returns to U.S. cancer institute
Reuters - WHO study has no clear answer on phones and cancer
Reuters - Business Group Joins Suit on Health Law
The New York Times - Exclusive: Obscure biotech Regeneron on verge of big league
Reuters - FDA to look into gene tests to be sold at Walgreen
Reuters - Walgreen Stores to Sell Spit-and-Mail Gene Testing Kits in U.S.
Bloomberg - Merck to Seek U.S. Approval for 5 New Drugs in 2010
Bloomberg - New Obama Strategy Treats ‘War’ on Drugs as Public Health Issue
Bloomberg - Memo to boss: 11-hour days are bad for the heart
Reuters - Florida Suit Poses a Challenge to Health Care Law
The New York Times - Glaxo Said to Pay $60 Million in Avandia Settlements
Bloomberg - Keeping Junior on Parent’s Insurance Is a Tax Benefit
Bloomberg - Payment Offers to Egg Donors Prompt Scrutiny
The New York Times - That Pill You Took? It May Well Be Theirs
The New York Times - Health insurers seek weaker reforms: Senator
Reuters - Glaxo Plans Two Deals as Competition Pushes Prices Up
Bloomberg - Genzyme OKs $2B buyback, mulls options for 3 units
The Boston Globe - Abbott’s Humira to Top Avastin as Best-Selling Drug
Bloomberg - Electronic medical orders may save lives
Reuters - Electronic medical orders may save lives
Reuters - Rethinking Generic Drugs vs. the Brands
The New York Times - Children’s Tylenol and Other Drugs Recalled
The New York Times - Supreme Court questions ban of biotech alfalfa
Associated Press - For $520 Million, AstraZeneca Settles Case Over Marketing of a D
The New York Times - The Search for Genes Leads to Unexpected Places
The New York Times - Drugmakers’ Overhaul Costs $105 Billion, Leerink Says
Bloomberg - Merck Revenue Cut by $170 Million From Health Law
Bloomberg - Havasupai Case Highlights Risks in DNA Research
The New York Times - Indian Tribe Wins Fight to Limit Research of Its DNA
The New York Times - Vatican to finance adult stem cell research
Associated Press - Cancer Fight: Unclear Tests for New Drug
The New York Times - Drug Sales May Advance to $1.1 Trillion on Emerging-Market Boom
Bloomberg - After Health Care Passage, Obama Pushes to Get It Rolling
The New York Times - Obama Health Team Turns to Carrying Out Law
The New York Times - Astellas Won’t Raise OSI Bid on FDA Decision Alone
Bloomberg - Test predicts effects of Amgen cancer drug
Reuters - Lilly First-Quarter Profit Falls on Health Overhaul
Bloomberg - Georgia Insurance Commissioner Balks at Request on New Health Law
The New York Times - DNA egg swap prevents rare diseases in babies
Reuters - Roche Shuns ‘Not Invented Here Syndrome’ to Boost Sales, Profit
Bloomberg - Cooking with the Genzyme Recipe: New Players Funding Rare Disease Drugs in Boston
Xconomy - Australia’s Rudd Promises Aged Care Spending in Health Overhaul
Bloomberg - Study Sees a Slant in Articles on Drug
The New York Times - Health Care Overhaul May Help a Fund Sector
The New York Times - DEALTALK-Bay St says life sciences fare better in U.S.
Reuters - For Many, Health Law Offers a Chance for Preventive Care
The New York Times - Gene found that may predict lung cancer in smokers
Reuters - U.S. sugar group says sugar not to blame for obesity
Reuters - Sphera Health Fund Shuns Teva Shares for ‘Cheap’ Pfizer, Sanofi
Bloomberg - An Elite Team of Sleuths, Saving Lives in Obscurity
The New York Times - The Next Policy Battle For Biotech After Healthcare Reform
Xconomy - Top biotech executives differ on health care law
The Boston Globe - Pfizer Gives Details on Payments to Doctors
The New York Times - Judge Invalidates Human Gene Patent
The New York Times - States' leaders clash over healthcare lawsuits
Reuters - Cost burden of chronic illness in Asia growing
Reuters - Health reform faces big test with implementation
Reuters - Health Reform Will Set Off Biotech Tax Credit Rush
Forbes - Congress’s Final Votes on Health Care Set Stage for Sales Job
Bloomberg - Pfizer Told to Pay $142.1 Million for Neurontin Marketing Fraud
Bloomberg - More Doctors Giving Up Private Practices
The New York Times - Final Votes in Congress Cap Battle on Health Bill
The New York Times - Doctors’ Thoughts on Cutting Health Care Costs
The New York Times - Sex virus blamed for rise in head and neck cancers
Reuters - Healthcare costs burden more Americans: study
Reuters - U.S. Stocks Rise as Drug Shares Rally After House OKs Overhaul
Bloomberg - U.S. employer healthcare costs up 7.3 percent in 2009
Reuters - In Health Care Reform, Boons for Hospitals and Drug Makers
The New York Times - For Consumers, Clarity on Health Care Changes
The New York Times - Obama Hails Vote on Health Care as Answering ‘the Call of History’
The New York Times - Democrats Gain Support as They Move on Health Vote
Bloomberg - House Democrats see momentum on health bill
Reuters - A Company Races to Keep a Drug Patent
The New York Times - Gay Men and Lesbians Barred From Some Clinical Trials
The New York Times - Fine-Tuning Led to Health Bill’s $940 Billion Price Tag
The New York Times - Insurer targeted HIV patients to drop coverage
Reuters - Health Bill Faces Delay as Democrats Tinker With Cost
Bloomberg - Democrats Consider New Moves for Health Bill
The New York Times - Kucinich Switches Vote on Health Care
The New York Times - Judge Won’t Bar Modified-Beet Planting Immediately
BusinessWeek - Myriad breast cancer patent very broad, study finds
Reuters - Obama’s C.D.C. Director, Wielding a Big Broom
The New York Times - Obama Tries to Personalize the Health Care Bill
The New York Times - With Medicaid Cuts, Doctors and Patients Drop Out
The New York Times - Pelosi Signals Aim to Pass Health-Care Bill Before Obama Trip
Bloomberg - Birth-Control Pills Cut Cancer, Lengthen Women’s Lives in Study
Bloomberg - Plavix gets new FDA warning
Reuters - House panel to consider healthcare bill Monday
Reuters - U.S. court rules again against vaccine-autism claims
Reuters - Democrats Struggle to Finish Health Bill
The New York Times - Health Care’s Obstacle: No Will to Cut
The New York Times - House, Senate Leaders Agree on Most of Health Bill
Bloomberg - Infection Defense May Spur Alzheimer’s
The New York Times - Disease Cause Is Pinpointed With Genome
The New York Times - Democrats move closer to healthcare deal
Reuters - For Many House Democrats, Cost Is the Concern
The New York Times - End-of-Life Warning at $618,616 Makes Me Wonder Was It Worth It
Bloomberg - Obama’s Health-Care Path May Face ‘War’ in Congress
Bloomberg - In Final Push, Obama Urges ‘Up-or-Down’ Vote on Health
The New York Times - Consumer group sues California health insurer
Reuters
Back « 1 2 3 4 5 6 7 8 ... » Next
.gif)
.png){kind=small} |
 |